<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083377</url>
  </required_header>
  <id_info>
    <org_study_id>CLOZASEV</org_study_id>
    <nct_id>NCT05083377</nct_id>
  </id_info>
  <brief_title>Clozapine Use Pattern in the Province of Seville</brief_title>
  <official_title>Clozapine Use Pattern in the Province of Seville</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Pública Andaluza para la gestión de la Investigación en Sevilla</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with a diagnosis of schizophrenia (F20 of ICD-10) under treatment with clozapine in&#xD;
      the province of Seville. The use of clozapine, variability between centers and treatment&#xD;
      modification will be identified.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 8, 2020</start_date>
  <completion_date type="Actual">September 8, 2021</completion_date>
  <primary_completion_date type="Actual">September 8, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify the pattern of clozapine use in the province of Seville</measure>
    <time_frame>year 2018</time_frame>
    <description>Identify the pattern of clozapine use in the province of Seville</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analyze the variability between centers or professionals</measure>
    <time_frame>year 2018</time_frame>
    <description>Analyze the variability between centers or professionals</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analyze the changes in the course of the disease since the prescription of clozapine</measure>
    <time_frame>year 2018</time_frame>
    <description>Analyze the changes in the course of the disease since the prescription of clozapine</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">600</enrollment>
  <condition>Schizophrenia and Related Disorders</condition>
  <arm_group>
    <arm_group_label>Patients who have been prescribed clozapine during 2018</arm_group_label>
    <description>Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have been prescribed (initially or regularly) clozapine during 2018, based on&#xD;
        the casuistry provided by the Pharmacy service of the different hospitals.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who have been prescribed (initially or regularly) clozapine during 2018, based on&#xD;
        the casuistry provided by the Pharmacy service of the different hospitals.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Parkinson's disease&#xD;
&#xD;
          -  Dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benedicto Crespo Facorro, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>benedicto.crespo.sspa@juntadeandalucia.es</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clozapine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

